Compare BHVN & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | MQ |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2022 | 2021 |
| Metric | BHVN | MQ |
|---|---|---|
| Price | $14.53 | $15.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 10 |
| Target Price | ★ $29.08 | $5.36 |
| AVG Volume (30 Days) | ★ 1.8M | 1.1M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $624,884,000.00 |
| Revenue This Year | N/A | $16.89 |
| Revenue Next Year | N/A | $16.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 23.25 |
| 52 Week Low | $7.48 | $3.70 |
| 52 Week High | $18.57 | $18.69 |
| Indicator | BHVN | MQ |
|---|---|---|
| Relative Strength Index (RSI) | 52.79 | 51.03 |
| Support Level | $13.84 | $15.08 |
| Resistance Level | $15.79 | $17.79 |
| Average True Range (ATR) | 0.65 | 0.77 |
| MACD | 0.04 | -0.51 |
| Stochastic Oscillator | 75.92 | 12.61 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.